Issue Date: June 25, 2012
HHS Creates Vaccine, Biodefense Centers
The Department of Health & Human Services is investing about $400 million in three new centers that aim to bring vaccines to market quickly and affordably in the event of an emergency such as pandemic influenza or a bioterrorist attack. The facilities, which are expected to become operational in 2014 and 2015, are being created as public-private partnerships between the federal government and small biotech firms, . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society